Research graph
References from Innovative nanomedicine strategies for precision-controlled targeted drug delivery: recent preclinical progress. Local targets link to admitted publications; unresolved targets remain external evidence.
The use of computational approaches to design nanodelivery systems
10.3390/nano15171354 · 2025 · External reference
Nanomedicines: emerging platforms in smart chemotherapy Treatment—A recent review
10.3390/ph17030315 · 2024 · External reference
Tumor-targeted nanomedicines for cancer theranostics
10.1016/j.phrs.2016.11.014 · 2017 · External reference
An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites
10.1111/jphp.13098 · 2019 · External reference
Targeted and biomimetic nanoparticles for atherosclerosis therapy: a review of emerging strategies
10.3390/biomedicines13071720 · 2025 · External reference
Platelet hitchhiking vascular-disrupting agents for self-amplified tumor-targeting therapy
10.1186/s12951-025-03262-9 · 2025 · External reference
Unresolved reference
2017 · External reference
Nanocarriers for targeted drug delivery in the vascular system: focus on endothelium
10.1186/s12951-024-02892-9 · 2024 · External reference
A novel carrier-free nanoparticle with stable distinctive three-dimensional structure for tumor-targeted precision chemoimmunotherapy
10.1186/s12951-025-03568-8 · 2025 · External reference
Minimum information reporting in bio–nano experimental literature
10.1038/s41565-018-0246-4 · 2018 · External reference
Nanocarrier drug delivery system: promising platform for targeted depression therapy
10.3389/fphar.2024.1435133 · 2024 · External reference
Actively targeted nanomedicines in breast cancer: from pre-clinal investigation to clinic
10.3390/cancers14051198 · 2022 · External reference
Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting
10.1038/s41392-020-00342-0 · 2020 · External reference
Precision drug delivery to the central nervous system using engineered nanoparticles
10.1038/s41578-024-00695-w · 2024 · External reference
Microfluidic devices: a tool for nanoparticle synthesis and performance evaluation
10.1021/acsnano.3c01117 · 2023 · External reference
A systematic review of nanocarriers used in medicine and Beyond—Definition and categorization framework
10.1186/s12951-025-03113-7 · 2025 · External reference
Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes
2001 · External reference
Nanocarriers for cutting-edge cancer immunotherapies
10.1186/s12967-025-06435-0 · 2025 · External reference
Unresolved reference
2008 · External reference
Unresolved reference
2009 · External reference
Advances in nanoparticles in targeted drug Delivery—A review
10.1016/j.rsurfi.2025.100529 · 2025 · External reference
Comprehensive analysis of the tumor targeting efficiency of functionalized nanoparticles in an immunocompetent environment
10.1038/s41598-025-22151-7 · 2025 · External reference
Advancements in nano-based drug delivery systems for therapeutics: a comprehensive review
10.1039/d5pm00179j · 2026 · External reference
Anti-inflammation-based treatment of atherosclerosis using gliclazide-loaded biomimetic nanoghosts
10.1038/s41598-023-41136-y · 2023 · External reference
Nanomedicine: the effective role of nanomaterials in healthcare from diagnosis to therapy
10.3390/pharmaceutics17080987 · 2025 · External reference
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models
10.1158/0008-5472.can-05-4199 · 2006 · External reference
New paradigm in combination therapy of siRNA with chemotherapeutic drugs for effective cancer therapy
10.1016/j.crphar.2022.100103 · 2022 · External reference
64Cu-MM-302 positron emission tomography quantifies variability of enhanced permeability and retention of nanoparticles in relation to treatment response in patients with metastatic breast cancer
10.1158/1078-0432.ccr-16-3193 · 2017 · External reference
Artificial exosomes for translational nanomedicine
10.1186/s12951-021-00986-2 · 2021 · External reference
Responsive nanomedicine strategies achieve pancreatic cancer precise theranostics
10.1016/j.bioactmat.2025.08.012 · 2025 · External reference
A programmable platelet Theranostic platform for adaptive multi-stage delivery and synergistic immunotherapy in atherosclerosis
10.1038/s41467-025-61789-9 · 2025 · External reference
The smart drug delivery system and its clinical potential
10.7150/thno.14858 · 2016 · External reference
Current research trends of nanomedicines
10.1016/j.apsb.2023.05.018 · 2023 · External reference
Exosome-powered neuropharmaceutics: unlocking the blood-brain barrier for next-gen therapies
10.1186/s12951-025-03352-8 · 2025 · External reference
Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics
10.7150/thno.38069 · 2020 · External reference
Engineering precision nanoparticles for drug delivery
10.1038/s41573-020-0090-8 · 2021 · External reference
Safety and pharmacokinetics of MM-302, a HER2-targeted antibody–liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study
10.1038/s41416-018-0235-2 · 2018 · External reference
Targeted-theranostic nanoparticles induce anti-tumor immune response in lung cancer
10.1186/s12951-025-03542-4 · 2025 · External reference
Engineered exosomes: advanced nanocarriers for targeted therapy and drug delivery in hematological malignancies
10.1186/s12645-025-00334-1 · 2025 · External reference
Recent advancements in stimuli responsive drug delivery platforms for active and passive cancer targeting
10.3390/cancers13040670 · 2021 · External reference
Artificial intelligence and machine learning guided optimization in drug delivery
10.1016/j.addr.2026.115781 · 2026 · External reference
Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery
10.1186/s12943-025-02357-z · 2025 · External reference
Recent advances in potential drug nanocarriers for CNS disorders: a review
10.1186/s12938-025-01474-6 · 2025 · External reference
The entry of nanoparticles into solid tumours
10.1038/s41563-019-0566-2 · 2020 · External reference
Next-generation nanocarriers for precision antitumor therapy: from passive targeting to intelligent response
10.37349/etat.2025.1002355 · 2025 · External reference
Evaluation of nanoparticle drug-delivery systems used in preclinical studies
10.4155/tde-2020-0116 · 2021 · External reference
Stimuli-responsive nanomaterials for the precision delivery of mRNA cancer vaccines
10.1016/j.nwnano.2025.100147 · 2025 · External reference
Nanoplatforms for targeted stimuli-responsive drug delivery: a review of platform materials and stimuli-responsive release and targeting mechanisms
10.3390/nano11030746 · 2021 · External reference
Allosteric targeted drug delivery for enhanced blood-brain barrier penetration via mimicking transmembrane domain interactions
10.1038/s41467-025-58746-x · 2025 · External reference
Biomimetic nanoparticles for basic drug delivery
10.3390/pharmaceutics16101306 · 2024 · External reference
Advances in nanomaterials for precision drug delivery: insights into pharmacokinetics and toxicity
10.34172/bi.30573 · 2024 · External reference
Unresolved reference
1999 · External reference
Unresolved reference
2013 · External reference
Unresolved reference
2018 · External reference
Unresolved reference
2022 · External reference
Targeting strategies for improving the efficacy of nanomedicine in oncology
10.3762/bjnano.10.16 · 2019 · External reference
Stimuli-responsive programmed specific targeting in nanomedicine
10.1021/acsnano.6b00870 · 2016 · External reference
Recent progress of nanocarrier-based therapy for solid malignancies
10.3390/cancers12102783 · 2020 · External reference
Recent advances in cell membrane coated-nanoparticles as drug delivery systems for tackling urological diseases
10.3390/pharmaceutics15071899 · 2023 · External reference
Recent studies and progress in the intratumoral administration of nano-sized drug delivery systems
10.3390/nano13152225 · 2023 · External reference
